These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26067083)

  • 21. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.
    Oh JY; Sung YA; Lee HJ
    Obesity (Silver Spring); 2013 Aug; 21(8):1690-4. PubMed ID: 23585246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome.
    Ko JK; Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Ho PC; Ng EH
    Gynecol Endocrinol; 2016; 32(5):390-4. PubMed ID: 26699091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.
    O'Connor A; Phelan N; Tun TK; Boran G; Gibney J; Roche HM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1378-85. PubMed ID: 20080859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.
    Başar Gökcen B; Akdevelioğlu Y; Canan S; Bozkurt N
    Eat Weight Disord; 2021 Jun; 26(5):1581-1593. PubMed ID: 32772321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
    Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
    Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between visceral adiposity index, hirsutism and cardiometabolic risk factors in women with polycystic ovarian syndrome: A cross-sectional study.
    Fonseka S; Subhani B; Wijeyaratne CN; Gawarammana IB; Kalupahana NS; Ratnatunga N; Rosairo S; Vithane KP
    Ceylon Med J; 2019 Sep; 64(3):111-117. PubMed ID: 32120461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.
    Ayina CN; Noubiap JJ; Etoundi Ngoa LS; Boudou P; Gautier JF; Mengnjo MK; Mbanya JC; Sobngwi E
    Lipids Health Dis; 2016 May; 15():96. PubMed ID: 27189377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity.
    Aydogdu A; Tasci I; Kucukerdonmez O; Tapan S; Aydogdu S; Aydogan U; Sonmez A; Yazici M; Azal O
    Gynecol Endocrinol; 2013 Feb; 29(2):152-5. PubMed ID: 22849614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
    Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
    Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
    Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.